Ana Quiroga‐Varela

1.9k total citations · 1 hit paper
26 papers, 1.2k citations indexed

About

Ana Quiroga‐Varela is a scholar working on Neurology, Cellular and Molecular Neuroscience and Pathology and Forensic Medicine. According to data from OpenAlex, Ana Quiroga‐Varela has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 12 papers in Cellular and Molecular Neuroscience and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Ana Quiroga‐Varela's work include Parkinson's Disease Mechanisms and Treatments (15 papers), Neurological disorders and treatments (12 papers) and Neuroscience and Neuropharmacology Research (7 papers). Ana Quiroga‐Varela is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (15 papers), Neurological disorders and treatments (12 papers) and Neuroscience and Neuropharmacology Research (7 papers). Ana Quiroga‐Varela collaborates with scholars based in Spain, United States and Italy. Ana Quiroga‐Varela's co-authors include Inés Trigo‐Damas, Javier Blesa, Vernice Jackson‐Lewis, Concepció Marı́n, José Á. Obeso, María Rodríguez‐Oroz, Haritz Jiménez‐Urbieta, E. S. Brazhnik, Judith R. Walters and María J. Blanco‐Prieto and has published in prestigious journals such as Brain, Scientific Reports and Neuroscience.

In The Last Decade

Ana Quiroga‐Varela

23 papers receiving 1.2k citations

Hit Papers

Oxidative stress and Parkinson’s disease 2015 2026 2018 2022 2015 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Quiroga‐Varela Spain 12 569 393 330 209 156 26 1.2k
Inés Trigo‐Damas Spain 11 606 1.1× 362 0.9× 331 1.0× 191 0.9× 163 1.0× 18 1.2k
Vedad Delic United States 13 501 0.9× 234 0.6× 300 0.9× 199 1.0× 303 1.9× 28 1.0k
Elżbieta Lorenc‐Koci Poland 22 410 0.7× 501 1.3× 299 0.9× 105 0.5× 142 0.9× 69 1.2k
Thomas S. Guillot United States 20 651 1.1× 796 2.0× 380 1.2× 164 0.8× 143 0.9× 24 1.8k
Sudhakar Subramaniam United States 11 798 1.4× 477 1.2× 570 1.7× 422 2.0× 377 2.4× 19 1.7k
Yuehang Xu United States 13 598 1.1× 472 1.2× 500 1.5× 212 1.0× 110 0.7× 18 1.6k
Eugene Bok South Korea 18 349 0.6× 357 0.9× 365 1.1× 443 2.1× 245 1.6× 26 1.2k
Tomoyuki Kanda Japan 20 405 0.7× 472 1.2× 419 1.3× 119 0.6× 92 0.6× 34 1.3k
Maria José Diógenes Portugal 22 286 0.5× 913 2.3× 461 1.4× 317 1.5× 315 2.0× 50 1.8k

Countries citing papers authored by Ana Quiroga‐Varela

Since Specialization
Citations

This map shows the geographic impact of Ana Quiroga‐Varela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Quiroga‐Varela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Quiroga‐Varela more than expected).

Fields of papers citing papers by Ana Quiroga‐Varela

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Quiroga‐Varela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Quiroga‐Varela. The network helps show where Ana Quiroga‐Varela may publish in the future.

Co-authorship network of co-authors of Ana Quiroga‐Varela

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Quiroga‐Varela. A scholar is included among the top collaborators of Ana Quiroga‐Varela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Quiroga‐Varela. Ana Quiroga‐Varela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quiroga‐Varela, Ana, et al.. (2025). Luminex Multiplex Immunoassay for Proteomic Profiling of Cerebrospinal Fluid. Methods in molecular biology. 2914. 41–50.
2.
Guglielmini, Giuseppe, et al.. (2025). Assessment of clinical prognosis in autoimmune encephalitis: Girona score. Frontiers in Psychiatry. 16. 1447009–1447009.
3.
Zamarbide, Marta, Belén Gago, Javier Blesa, et al.. (2025). Resilience of striatal synaptic plasticity over early structural adaptations in premotor parkinsonism. npj Parkinson s Disease. 11(1). 146–146.
4.
Tamarit, Jordi, Elisa Cabiscol, Fabien Delaspre, et al.. (2024). Calcitriol Treatment Is Safe and Increases Frataxin Levels in Friedreich Ataxia Patients. Movement Disorders. 39(7). 1099–1108. 1 indexed citations
5.
Coll, Clàudia, María Buxó, Ester Quintana, et al.. (2023). Differences in metacognition between multiple sclerosis phenotypes: cognitive impairment and fatigue are key factors. Frontiers in Psychology. 14. 1163112–1163112. 1 indexed citations
6.
Quiroga‐Varela, Ana, et al.. (2023). Improving the efficiency of free kappa light chains as diagnostic biomarker of Multiple Sclerosis by using a novel algorithm. Multiple Sclerosis and Related Disorders. 79. 104997–104997. 4 indexed citations
7.
Zamarbide, Marta, Belén Gago, Enrique Santamaría, et al.. (2023). Hippocampal synaptic failure is an early event in experimental parkinsonism with subtle cognitive deficit. Brain. 146(12). 4949–4963. 11 indexed citations
8.
Coll, Clàudia, Ester Quintana, María Buxó, et al.. (2022). Oligoclonal IgM bands are a promising biomarker for long-term cognitive outcomes in multiple sclerosis. Multiple Sclerosis and Related Disorders. 68. 104397–104397. 4 indexed citations
9.
Jiménez‐Urbieta, Haritz, Belén Gago, Ana Quiroga‐Varela, et al.. (2020). Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats. Psychopharmacology. 237(8). 2419–2431. 5 indexed citations
10.
Quiroga‐Varela, Ana, et al.. (2020). [18F]-DPA-714 PET as a specific in vivo marker of early microglial activation in a rat model of progressive dopaminergic degeneration. European Journal of Nuclear Medicine and Molecular Imaging. 47(11). 2602–2612. 21 indexed citations
11.
Paz‐Alonso, Pedro M., Irene Navalpotro‐Gómez, Rosalía Dacosta‐Aguayo, et al.. (2019). Functional Inhibitory Control Dynamics in Impulse Control Disorders in Parkinson's Disease. Movement Disorders. 35(2). 316–325. 23 indexed citations
12.
Navalpotro‐Gómez, Irene, Rosalía Dacosta‐Aguayo, Antonio Martín‐Bastida, et al.. (2019). Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson’s disease patients with impulse control disorders. European Journal of Nuclear Medicine and Molecular Imaging. 46(10). 2065–2076. 10 indexed citations
13.
Navalpotro‐Gómez, Irene, Jinhee Kim, Pedro M. Paz‐Alonso, et al.. (2019). Disrupted salience network dynamics in Parkinson's disease patients with impulse control disorders. Parkinsonism & Related Disorders. 70. 74–81. 39 indexed citations
14.
Jiménez‐Urbieta, Haritz, Belén Gago, Ana Quiroga‐Varela, et al.. (2018). Pramipexole-induced impulsivity in mildparkinsonian rats: a model of impulse control disorders in Parkinson's disease. Neurobiology of Aging. 75. 126–135. 22 indexed citations
15.
Rey, Natalia López‐González del, Ana Quiroga‐Varela, Elisa Garbayo, et al.. (2018). Advances in Parkinson’s Disease: 200 Years Later. Frontiers in Neuroanatomy. 12. 113–113. 104 indexed citations
16.
Quiroga‐Varela, Ana, Esther Aguilar, Elena Iglesias, José Á. Obeso, & Concepció Marı́n. (2017). Short- and long-term effects induced by repeated 6-OHDA intraventricular administration: A new progressive and bilateral rodent model of Parkinson’s disease. Neuroscience. 361. 144–156. 11 indexed citations
17.
Filippo, Massimiliano Di, Antonio de Iure, Carmela Giampà, et al.. (2016). Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis. Scientific Reports. 6(1). 20926–20926. 78 indexed citations
18.
Gago, Belén, Ana Quiroga‐Varela, Carlos Juri, et al.. (2015). Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: A longitudinal in-vivo study. Neurobiology of Disease. 77. 165–172. 17 indexed citations
19.
Tozzi, Alessandro, Antonio de Iure, Michela Tantucci, et al.. (2015). Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system. Frontiers in Cellular Neuroscience. 9. 192–192. 44 indexed citations
20.
Quiroga‐Varela, Ana, Judith R. Walters, E. S. Brazhnik, Concepció Marı́n, & José Á. Obeso. (2013). What basal ganglia changes underlie the parkinsonian state? The significance of neuronal oscillatory activity. Neurobiology of Disease. 58. 242–248. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026